Related Experiment Video
Updated: Aug 9, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2
Ping Wang1, Hua Gao, Yanxiang Ni
1Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, People's Republic of China.
Abstract:
Oncoprotein Mdm2 is a master negative regulator of the tumor suppressor p53 and has been recently shown to regulate the ubiquitination of beta-arrestin 2, an important adapter and scaffold in signaling of G-protein-coupled receptors (GPCRs). However, whether beta-arrestin 2 has any effect on the function of Mdm2 is still unclear. Our current results demonstrated that the binding of Mdm2 to beta-arrestin 2 was significantly enhanced by stimulation of GPCRs. Activation of GPCRs led to formation of a ternary complex of Mdm2, beta-arrestin 2, and GPCRs and thus recruited Mdm2 to GPCRs at plasma membrane. Moreover, the binding of beta-arrestin 2 to Mdm2 suppressed the self-ubiquitination of Mdm2 and consequently reduced the Mdm2-mediated p53 degradation and ubiquitination. Further experiments revealed that overexpression of beta-arrestin 2 enhanced the p53-mediated apoptosis while suppression of endogenous beta-arrestin 2 expression by RNA interference technology considerably attenuated the p53-mediated apoptosis. Our study thus suggests that beta-arrestin 2 may serve as a cross-talk linker between GPCR and p53 signaling pathways.
Insights
Beta-arrestin 2 links G-protein-coupled receptor (GPCR) signaling to the tumor suppressor p53 pathway. It inhibits Mdm2, reducing p53 degradation and enhancing apoptosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Mdm2 is a key negative regulator of the tumor suppressor p53.
- Beta-arrestin 2 is an adapter protein involved in G-protein-coupled receptor (GPCR) signaling.
- The interaction and functional relationship between Mdm2 and beta-arrestin 2 were previously unclear.
Purpose of the Study:
- To investigate the effect of beta-arrestin 2 on Mdm2 function.
- To explore the role of GPCR signaling in the Mdm2-beta-arrestin 2 interaction.
- To elucidate the impact of this interaction on p53 stability and apoptosis.
Main Methods:
- GPCR stimulation assays.
- Co-immunoprecipitation to detect protein interactions.
- Western blotting to assess protein ubiquitination and degradation.
- RNA interference to modulate beta-arrestin 2 expression.
- Apoptosis assays.
Main Results:
- GPCR stimulation significantly enhanced the binding of Mdm2 to beta-arrestin 2.
- A ternary complex of Mdm2, beta-arrestin 2, and GPCRs was formed at the plasma membrane.
- Beta-arrestin 2 binding to Mdm2 suppressed Mdm2 self-ubiquitination, reducing Mdm2-mediated p53 degradation.
- Overexpression of beta-arrestin 2 increased p53-mediated apoptosis, while its suppression attenuated it.
Conclusions:
- Beta-arrestin 2 negatively regulates Mdm2 activity through direct binding.
- GPCR signaling modulates the Mdm2-beta-arrestin 2 interaction.
- Beta-arrestin 2 plays a crucial role in stabilizing p53 and promoting apoptosis.
- Beta-arrestin 2 acts as a molecular bridge connecting GPCR and p53 signaling pathways.
Related Concept Videos
Negative Regulator Molecules
Master Transcription Regulators
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Abnormal Proliferation
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade

